• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过检测肾功能衰竭患者血浆中人心房利钠肽(h-ANP)浓度来诊断液体超负荷。

Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure.

作者信息

Eisenhauer T, Talartschik J, Scheler F

出版信息

Klin Wochenschr. 1986;64 Suppl 6:68-72.

PMID:2948067
Abstract

There are no reliable parameters for the detection of fluid overload in anuric patients. In 70 patients on regular haemodialysis (HD) or haemofiltration (HF) treatment, plasma ANP IR concentrations were determined by radioimmunoassay and compared to 43 controls with normal renal function. ANP IR levels were markedly elevated immediately before HD or HF (m 82 fmol/ml) compared to ANP IR plasma concentrations after HD or HF (m 42 fmol/ml) and to ANP IR levels of healthy controls (m 19 fmol/ml). ANP IR was detected in haemofiltrates and found to be eliminated by HF. During isovolemic HF, ANP IR levels remained constant suggesting that ANP synthesis is much higher than elimination by HF and that the decrease in circulating volume at the end of HF or HD is the main stimulus for a lower secretion rate of ANP. Elevated ANP IR levels at the end of HD/HF were found to be associated with fluid overload even without clinical or radiographic symptoms. Consistent weight reduction was followed by a decrease of ANP IR levels.

摘要

对于无尿患者,目前尚无检测液体超负荷的可靠参数。对70例接受常规血液透析(HD)或血液滤过(HF)治疗的患者,采用放射免疫分析法测定其血浆心钠素免疫反应(ANP IR)浓度,并与43例肾功能正常的对照者进行比较。与血液透析或血液滤过治疗后(平均42 fmol/ml)及健康对照者(平均19 fmol/ml)的血浆ANP IR浓度相比,血液透析或血液滤过治疗前ANP IR水平显著升高(平均82 fmol/ml)。在血液滤出液中检测到ANP IR,且发现其可被血液滤过清除。在等容血液滤过期间,ANP IR水平保持恒定,这表明ANP的合成远高于血液滤过的清除量,且血液滤过或血液透析结束时循环血容量的减少是ANP分泌率降低的主要刺激因素。即使没有临床或影像学症状,也发现血液透析/血液滤过结束时升高的ANP IR水平与液体超负荷有关。持续减重后ANP IR水平下降。

相似文献

1
Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure.通过检测肾功能衰竭患者血浆中人心房利钠肽(h-ANP)浓度来诊断液体超负荷。
Klin Wochenschr. 1986;64 Suppl 6:68-72.
2
[Is the plasma ANP level an index of volume expansion in dialysis patients?].
Z Kardiol. 1988;77 Suppl 2:72-7.
3
[Clinical relevance of the determination of plasma atrial natriuretic peptide in children with chronic renal failure].
Z Kardiol. 1988;77 Suppl 2:61-4.
4
[Levels of immunoreactive atrial natriuretic peptide in the blood of children on hemodialysis therapy].[接受血液透析治疗儿童血液中免疫反应性心房利钠肽水平]
Srp Arh Celok Lek. 1992 Sep-Oct;120(9-10):277-80.
5
Molecular forms of human brain natriuretic peptide (BNP) in plasma of patients on hemodialysis (HD).血液透析(HD)患者血浆中脑钠肽(BNP)的分子形式
Clin Nephrol. 1995 Apr;43(4):237-42.
6
Plasma levels of atrial natriuretic peptide (ANP) in volume expanded patients: response to fluid removal by continuous pump driven hemofiltration.容量扩张患者的血浆心房利钠肽(ANP)水平:对持续泵驱动血液滤过清除液体的反应。
Klin Wochenschr. 1986;64 Suppl 6:112-4.
7
Plasma concentrations of natriuretic peptides in patients on hemodialysis.接受血液透析治疗患者的血浆利钠肽浓度
Res Commun Mol Pathol Pharmacol. 1996 Apr;92(1):19-30.
8
Plasma human brain natriuretic peptide in chronic renal failure.慢性肾衰竭患者的血浆人脑钠肽
Clin Nephrol. 1995 Nov;44 Suppl 1:S61-4.
9
Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis.
Clin Nephrol. 1994 Jul;42(1):50-3.
10
Plasma levels of atrial natriuretic peptide and digoxin-like immunoreactive substances in intermittent peritoneal dialysis.间歇性腹膜透析时血浆心钠素及洋地黄样免疫反应物质水平
Adv Perit Dial. 1989;5:20-3.

引用本文的文献

1
The Conundrum of Volume Status Assessment: Revisiting Current and Future Tools Available for Physicians at the Bedside.容量状态评估的难题:重新审视床边医生可用的现有及未来工具
Cureus. 2021 May 26;13(5):e15253. doi: 10.7759/cureus.15253.
2
Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence.利钠肽作为充血状态的生物标志物:心肾差异
Dis Markers. 2017;2017:1454986. doi: 10.1155/2017/1454986. Epub 2017 Jun 18.
3
The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients.
利钠肽在血液透析患者容量评估及死亡率预测中的作用
BMC Nephrol. 2015 Dec 29;16:218. doi: 10.1186/s12882-015-0212-4.
4
Changes of molecular forms of atrial natriuretic peptide after treatment for congestive heart failure.充血性心力衰竭治疗后心房利钠肽分子形式的变化
Klin Wochenschr. 1988 Aug 1;66(15):675-81. doi: 10.1007/BF01726925.
5
The use of a monoclonal antibody for the determination of atrial natriuretic peptides in human plasma.一种单克隆抗体在人血浆中利钠肽测定中的应用。
Klin Wochenschr. 1987 Jul 15;65(12):533-7. doi: 10.1007/BF01727617.
6
[Modification of atrial natriuretic peptide (ANP) and cyclic GMP by hemofiltration and hemodialysis].[血液滤过和血液透析对心房利钠肽(ANP)和环磷酸鸟苷(cGMP)的影响]
Klin Wochenschr. 1988 Sep 15;66(18):940-5. doi: 10.1007/BF01728958.
7
Binding sites of atrial natriuretic peptide in human renal tissue-quantification by in vitro receptor autoradiography.人肾组织中心房钠尿肽结合位点——体外受体放射自显影定量分析
Klin Wochenschr. 1988 Apr 1;66(7):303-7. doi: 10.1007/BF01727517.
8
Atrial natriuretic peptide and sodium homeostasis in chronic renal failure.慢性肾衰竭时的心房利钠肽与钠稳态
Pediatr Nephrol. 1989 Oct;3(4):397-400. doi: 10.1007/BF00850214.
9
[Behavior of the renal functional reserve in type I diabetic patients: effect of ACE-inhibition].I型糖尿病患者肾功储备的表现:血管紧张素转换酶抑制剂的作用
Klin Wochenschr. 1990 Aug 2;68(15):750-7. doi: 10.1007/BF01647243.
10
[Atrial natriuretic factor levels and pressure in the pulmonary circulation before and after coronary dilatation].[冠状动脉扩张前后心房利钠因子水平与肺循环压力]
Klin Wochenschr. 1990 Aug 17;68(16):823-9. doi: 10.1007/BF01796272.